Cronos Group Inc.CRONEarnings & Financial Report
Nasdaq · Health Care · Medicinal Chemicals & Botanical Products
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Altria Group, Inc. | 41.00% | 156.6M | — | 2024-04-25 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-19 | Anna Shlimak | See Remarks | Option exercise | 28.4K | $0.00 | $0 |
| 2026-03-15 | Anna Shlimak | See Remarks | Option exercise | 45.2K | $0.00 | $0 |
| 2026-03-15 | Arye Weigensberg | See Remarks | Option exercise | 24.2K | $0.00 | $0 |
| 2026-03-15 | Doucet Terrence Gregory Joseph | See Remarks | Option exercise | 23.9K | $0.00 | $0 |
| 2026-03-15 | GORENSTEIN MICHAEL RYAN | See remarks below | Option exercise | 324.5K | $0.00 | $0 |
| 2026-03-15 | Shannon Buggy | See Remarks | Option exercise | 20.9K | $0.00 | $0 |
| 2026-03-15 | JACOBSON JEFFREY DAVID | Chief Growth Officer | Option exercise | 59.2K | $0.00 | $0 |
| 2026-03-12 | Adam Wagner | See remarks | Option exercise | 15.7K | $0.00 | $0 |
| 2026-03-12 | Arye Weigensberg | See Remarks | Option exercise | 26.8K | $0.00 | $0 |
| 2026-03-12 | GORENSTEIN MICHAEL RYAN | See remarks below | Option exercise | 339.9K | $0.00 | $0 |
1–10 of 21
Page 1 / 3